Jazz Pharmaceuticals

Price —

Potential 0 Risk 0

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Nothing yet

News Page 1 of 1

A J

Jazz Pharmaceuticals to Acquire Actio Biosciences for $820 Million to Expand Rare Epilepsy Portfolio

08/11/2026, 08:37 AM business announcement Actio Biosciences Jazz Pharmaceuticals

Jazz Pharmaceuticals is set to acquire Actio Biosciences for $820 million, with potential additional payments of up to $500 million, significantly enhancing its portfolio in rare epilepsy treatments.